Cargando…

Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study

BACKGROUND: Human Heat Shock Protein 60 (hHSP60) has been implicated in autoimmunity through molecular mimicry, based on the high degree of homology with HSP65 of micro-organisms leading to autoimmune recognition of the human protein. Additionally, sequence homology between hHSP60 and myeloperoxidas...

Descripción completa

Detalles Bibliográficos
Autores principales: Slot, Marjan C, Theunissen, Ruud, van Paassen, Pieter, Damoiseaux, Jan GMC, Cohen Tervaert, Jan Willem
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526731/
https://www.ncbi.nlm.nih.gov/pubmed/16677376
http://dx.doi.org/10.1186/1740-2557-3-4
_version_ 1782128938586210304
author Slot, Marjan C
Theunissen, Ruud
van Paassen, Pieter
Damoiseaux, Jan GMC
Cohen Tervaert, Jan Willem
author_facet Slot, Marjan C
Theunissen, Ruud
van Paassen, Pieter
Damoiseaux, Jan GMC
Cohen Tervaert, Jan Willem
author_sort Slot, Marjan C
collection PubMed
description BACKGROUND: Human Heat Shock Protein 60 (hHSP60) has been implicated in autoimmunity through molecular mimicry, based on the high degree of homology with HSP65 of micro-organisms leading to autoimmune recognition of the human protein. Additionally, sequence homology between hHSP60 and myeloperoxidase (MPO) has been described. MPO is a major autoantigen in vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA). We hypothesized that infections may trigger the ANCA response against MPO through hHSP60. METHODS: In 86 consecutive patients with ANCA-associated vasculitis (AAV), anti-hHSP60 and anti-mycobacterial HSP65 were measured by ELISA. Patients were compared with 69 healthy controls (HC). Continuous data between groups were compared using Wilcoxon signed rank test and Kruskal-Wallis test with Dunn's post-test when appropriate. Correlations between data were derived using Spearman correlation. Odds ratios and 95% confidence intervals were obtained using Fisher's exact test. RESULTS: At diagnosis, median anti-mHSP65 level was higher in AAV (median [range]: 42.5 [0–500]), and subsequently in MPO-ANCA (44 [7–500]), compared to HC (22 [0–430]). Anti-hHSP60 levels in AAV were not higher compared to HC (18 [0–319] and 18.5 [0–98], respectively). However, in MPO-ANCA anti-hHSP60 levels were increased (32.5 [0–319]) compared to PR3-ANCA (13 [0–79]) and HC. We could not detect cross-reactivity between hHSP60 and MPO-ANCA. There was a correlation between anti-mHSP65 and anti-hHSP60 levels (r = 0.32, P = 0.003) but not between anti-hHSP60 and MPO-ANCA (r = -0.064, P = 0.69). CONCLUSION: Antibodies against mHSP65 are higher in AAV compared to HC, and anti-hHSP60 antibodies are higher in patients with MPO-ANCA than in patients with PR3-ANCA and HC. Although this finding may be indicative for cross-reactivity between MPO-ANCA and hHSP60, additional assays did not support this hypothesis.
format Text
id pubmed-1526731
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15267312006-08-04 Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study Slot, Marjan C Theunissen, Ruud van Paassen, Pieter Damoiseaux, Jan GMC Cohen Tervaert, Jan Willem J Autoimmune Dis Research BACKGROUND: Human Heat Shock Protein 60 (hHSP60) has been implicated in autoimmunity through molecular mimicry, based on the high degree of homology with HSP65 of micro-organisms leading to autoimmune recognition of the human protein. Additionally, sequence homology between hHSP60 and myeloperoxidase (MPO) has been described. MPO is a major autoantigen in vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA). We hypothesized that infections may trigger the ANCA response against MPO through hHSP60. METHODS: In 86 consecutive patients with ANCA-associated vasculitis (AAV), anti-hHSP60 and anti-mycobacterial HSP65 were measured by ELISA. Patients were compared with 69 healthy controls (HC). Continuous data between groups were compared using Wilcoxon signed rank test and Kruskal-Wallis test with Dunn's post-test when appropriate. Correlations between data were derived using Spearman correlation. Odds ratios and 95% confidence intervals were obtained using Fisher's exact test. RESULTS: At diagnosis, median anti-mHSP65 level was higher in AAV (median [range]: 42.5 [0–500]), and subsequently in MPO-ANCA (44 [7–500]), compared to HC (22 [0–430]). Anti-hHSP60 levels in AAV were not higher compared to HC (18 [0–319] and 18.5 [0–98], respectively). However, in MPO-ANCA anti-hHSP60 levels were increased (32.5 [0–319]) compared to PR3-ANCA (13 [0–79]) and HC. We could not detect cross-reactivity between hHSP60 and MPO-ANCA. There was a correlation between anti-mHSP65 and anti-hHSP60 levels (r = 0.32, P = 0.003) but not between anti-hHSP60 and MPO-ANCA (r = -0.064, P = 0.69). CONCLUSION: Antibodies against mHSP65 are higher in AAV compared to HC, and anti-hHSP60 antibodies are higher in patients with MPO-ANCA than in patients with PR3-ANCA and HC. Although this finding may be indicative for cross-reactivity between MPO-ANCA and hHSP60, additional assays did not support this hypothesis. BioMed Central 2006-05-05 /pmc/articles/PMC1526731/ /pubmed/16677376 http://dx.doi.org/10.1186/1740-2557-3-4 Text en Copyright © 2006 Slot et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Slot, Marjan C
Theunissen, Ruud
van Paassen, Pieter
Damoiseaux, Jan GMC
Cohen Tervaert, Jan Willem
Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
title Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
title_full Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
title_fullStr Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
title_full_unstemmed Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
title_short Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
title_sort evaluation of antibodies against human hsp60 in patients with mpo-anca associated glomerulonephritis: a cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526731/
https://www.ncbi.nlm.nih.gov/pubmed/16677376
http://dx.doi.org/10.1186/1740-2557-3-4
work_keys_str_mv AT slotmarjanc evaluationofantibodiesagainsthumanhsp60inpatientswithmpoancaassociatedglomerulonephritisacohortstudy
AT theunissenruud evaluationofantibodiesagainsthumanhsp60inpatientswithmpoancaassociatedglomerulonephritisacohortstudy
AT vanpaassenpieter evaluationofantibodiesagainsthumanhsp60inpatientswithmpoancaassociatedglomerulonephritisacohortstudy
AT damoiseauxjangmc evaluationofantibodiesagainsthumanhsp60inpatientswithmpoancaassociatedglomerulonephritisacohortstudy
AT cohentervaertjanwillem evaluationofantibodiesagainsthumanhsp60inpatientswithmpoancaassociatedglomerulonephritisacohortstudy